Global Oligonucleotide Therapeutics Drug Supply, Demand and Key Producers, 2023-2029
The global Oligonucleotide Therapeutics Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Many pharmaceutical companies were conducting research on oligonucleotide therapy, which employs chemically synthesized nucleotide-like small molecule drugs with potential specificity similar to that of therapeutic antibodies.
This report studies the global Oligonucleotide Therapeutics Drug demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Oligonucleotide Therapeutics Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Oligonucleotide Therapeutics Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Oligonucleotide Therapeutics Drug total market, 2018-2029, (USD Million)
Global Oligonucleotide Therapeutics Drug total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Oligonucleotide Therapeutics Drug total market, key domestic companies and share, (USD Million)
Global Oligonucleotide Therapeutics Drug revenue by player and market share 2018-2023, (USD Million)
Global Oligonucleotide Therapeutics Drug total market by Type, CAGR, 2018-2029, (USD Million)
Global Oligonucleotide Therapeutics Drug total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Oligonucleotide Therapeutics Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Biogen, Sarepta Therapeutics, Jazz Pharmaceuticals, Bausch & Lomb, Alnylam Pharmaceuticals, Dynavax Technologies, Kastle therapeutics and Akcea Therapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Oligonucleotide Therapeutics Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Oligonucleotide Therapeutics Drug Market, By Region:
1. How big is the global Oligonucleotide Therapeutics Drug market?
2. What is the demand of the global Oligonucleotide Therapeutics Drug market?
3. What is the year over year growth of the global Oligonucleotide Therapeutics Drug market?
4. What is the total value of the global Oligonucleotide Therapeutics Drug market?
5. Who are the major players in the global Oligonucleotide Therapeutics Drug market?
6. What are the growth factors driving the market demand?
Many pharmaceutical companies were conducting research on oligonucleotide therapy, which employs chemically synthesized nucleotide-like small molecule drugs with potential specificity similar to that of therapeutic antibodies.
This report studies the global Oligonucleotide Therapeutics Drug demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Oligonucleotide Therapeutics Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Oligonucleotide Therapeutics Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Oligonucleotide Therapeutics Drug total market, 2018-2029, (USD Million)
Global Oligonucleotide Therapeutics Drug total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Oligonucleotide Therapeutics Drug total market, key domestic companies and share, (USD Million)
Global Oligonucleotide Therapeutics Drug revenue by player and market share 2018-2023, (USD Million)
Global Oligonucleotide Therapeutics Drug total market by Type, CAGR, 2018-2029, (USD Million)
Global Oligonucleotide Therapeutics Drug total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Oligonucleotide Therapeutics Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Biogen, Sarepta Therapeutics, Jazz Pharmaceuticals, Bausch & Lomb, Alnylam Pharmaceuticals, Dynavax Technologies, Kastle therapeutics and Akcea Therapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Oligonucleotide Therapeutics Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Oligonucleotide Therapeutics Drug Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Antisense Oligonucleotide
- Aptamer
- Other
- Neuromuscular Diseases
- ATTR
- Hepatic VOD
- Other
- Biogen
- Sarepta Therapeutics
- Jazz Pharmaceuticals
- Bausch & Lomb
- Alnylam Pharmaceuticals
- Dynavax Technologies
- Kastle therapeutics
- Akcea Therapeutics
1. How big is the global Oligonucleotide Therapeutics Drug market?
2. What is the demand of the global Oligonucleotide Therapeutics Drug market?
3. What is the year over year growth of the global Oligonucleotide Therapeutics Drug market?
4. What is the total value of the global Oligonucleotide Therapeutics Drug market?
5. Who are the major players in the global Oligonucleotide Therapeutics Drug market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Oligonucleotide Therapeutics Drug Introduction
1.2 World Oligonucleotide Therapeutics Drug Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Oligonucleotide Therapeutics Drug Total Market by Region (by Headquarter Location)
1.3.1 World Oligonucleotide Therapeutics Drug Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Oligonucleotide Therapeutics Drug Market Size (2018-2029)
1.3.3 China Oligonucleotide Therapeutics Drug Market Size (2018-2029)
1.3.4 Europe Oligonucleotide Therapeutics Drug Market Size (2018-2029)
1.3.5 Japan Oligonucleotide Therapeutics Drug Market Size (2018-2029)
1.3.6 South Korea Oligonucleotide Therapeutics Drug Market Size (2018-2029)
1.3.7 ASEAN Oligonucleotide Therapeutics Drug Market Size (2018-2029)
1.3.8 India Oligonucleotide Therapeutics Drug Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Oligonucleotide Therapeutics Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Oligonucleotide Therapeutics Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Oligonucleotide Therapeutics Drug Consumption Value (2018-2029)
2.2 World Oligonucleotide Therapeutics Drug Consumption Value by Region
2.2.1 World Oligonucleotide Therapeutics Drug Consumption Value by Region (2018-2023)
2.2.2 World Oligonucleotide Therapeutics Drug Consumption Value Forecast by Region (2024-2029)
2.3 United States Oligonucleotide Therapeutics Drug Consumption Value (2018-2029)
2.4 China Oligonucleotide Therapeutics Drug Consumption Value (2018-2029)
2.5 Europe Oligonucleotide Therapeutics Drug Consumption Value (2018-2029)
2.6 Japan Oligonucleotide Therapeutics Drug Consumption Value (2018-2029)
2.7 South Korea Oligonucleotide Therapeutics Drug Consumption Value (2018-2029)
2.8 ASEAN Oligonucleotide Therapeutics Drug Consumption Value (2018-2029)
2.9 India Oligonucleotide Therapeutics Drug Consumption Value (2018-2029)
3 WORLD OLIGONUCLEOTIDE THERAPEUTICS DRUG COMPANIES COMPETITIVE ANALYSIS
3.1 World Oligonucleotide Therapeutics Drug Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Oligonucleotide Therapeutics Drug Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Oligonucleotide Therapeutics Drug in 2022
3.2.3 Global Concentration Ratios (CR8) for Oligonucleotide Therapeutics Drug in 2022
3.3 Oligonucleotide Therapeutics Drug Company Evaluation Quadrant
3.4 Oligonucleotide Therapeutics Drug Market: Overall Company Footprint Analysis
3.4.1 Oligonucleotide Therapeutics Drug Market: Region Footprint
3.4.2 Oligonucleotide Therapeutics Drug Market: Company Product Type Footprint
3.4.3 Oligonucleotide Therapeutics Drug Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Oligonucleotide Therapeutics Drug Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Oligonucleotide Therapeutics Drug Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Oligonucleotide Therapeutics Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Oligonucleotide Therapeutics Drug Consumption Value Comparison
4.2.1 United States VS China: Oligonucleotide Therapeutics Drug Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Oligonucleotide Therapeutics Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Oligonucleotide Therapeutics Drug Companies and Market Share, 2018-2023
4.3.1 United States Based Oligonucleotide Therapeutics Drug Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Oligonucleotide Therapeutics Drug Revenue, (2018-2023)
4.4 China Based Companies Oligonucleotide Therapeutics Drug Revenue and Market Share, 2018-2023
4.4.1 China Based Oligonucleotide Therapeutics Drug Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Oligonucleotide Therapeutics Drug Revenue, (2018-2023)
4.5 Rest of World Based Oligonucleotide Therapeutics Drug Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Oligonucleotide Therapeutics Drug Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Oligonucleotide Therapeutics Drug Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Oligonucleotide Therapeutics Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Antisense Oligonucleotide
5.2.2 Aptamer
5.2.3 Other
5.3 Market Segment by Type
5.3.1 World Oligonucleotide Therapeutics Drug Market Size by Type (2018-2023)
5.3.2 World Oligonucleotide Therapeutics Drug Market Size by Type (2024-2029)
5.3.3 World Oligonucleotide Therapeutics Drug Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Oligonucleotide Therapeutics Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Neuromuscular Diseases
6.2.2 ATTR
6.2.3 Hepatic VOD
6.2.4 Other
6.2.5 Other
6.3 Market Segment by Application
6.3.1 World Oligonucleotide Therapeutics Drug Market Size by Application (2018-2023)
6.3.2 World Oligonucleotide Therapeutics Drug Market Size by Application (2024-2029)
6.3.3 World Oligonucleotide Therapeutics Drug Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Biogen
7.1.1 Biogen Details
7.1.2 Biogen Major Business
7.1.3 Biogen Oligonucleotide Therapeutics Drug Product and Services
7.1.4 Biogen Oligonucleotide Therapeutics Drug Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Biogen Recent Developments/Updates
7.1.6 Biogen Competitive Strengths & Weaknesses
7.2 Sarepta Therapeutics
7.2.1 Sarepta Therapeutics Details
7.2.2 Sarepta Therapeutics Major Business
7.2.3 Sarepta Therapeutics Oligonucleotide Therapeutics Drug Product and Services
7.2.4 Sarepta Therapeutics Oligonucleotide Therapeutics Drug Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Sarepta Therapeutics Recent Developments/Updates
7.2.6 Sarepta Therapeutics Competitive Strengths & Weaknesses
7.3 Jazz Pharmaceuticals
7.3.1 Jazz Pharmaceuticals Details
7.3.2 Jazz Pharmaceuticals Major Business
7.3.3 Jazz Pharmaceuticals Oligonucleotide Therapeutics Drug Product and Services
7.3.4 Jazz Pharmaceuticals Oligonucleotide Therapeutics Drug Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Jazz Pharmaceuticals Recent Developments/Updates
7.3.6 Jazz Pharmaceuticals Competitive Strengths & Weaknesses
7.4 Bausch & Lomb
7.4.1 Bausch & Lomb Details
7.4.2 Bausch & Lomb Major Business
7.4.3 Bausch & Lomb Oligonucleotide Therapeutics Drug Product and Services
7.4.4 Bausch & Lomb Oligonucleotide Therapeutics Drug Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Bausch & Lomb Recent Developments/Updates
7.4.6 Bausch & Lomb Competitive Strengths & Weaknesses
7.5 Alnylam Pharmaceuticals
7.5.1 Alnylam Pharmaceuticals Details
7.5.2 Alnylam Pharmaceuticals Major Business
7.5.3 Alnylam Pharmaceuticals Oligonucleotide Therapeutics Drug Product and Services
7.5.4 Alnylam Pharmaceuticals Oligonucleotide Therapeutics Drug Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Alnylam Pharmaceuticals Recent Developments/Updates
7.5.6 Alnylam Pharmaceuticals Competitive Strengths & Weaknesses
7.6 Dynavax Technologies
7.6.1 Dynavax Technologies Details
7.6.2 Dynavax Technologies Major Business
7.6.3 Dynavax Technologies Oligonucleotide Therapeutics Drug Product and Services
7.6.4 Dynavax Technologies Oligonucleotide Therapeutics Drug Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Dynavax Technologies Recent Developments/Updates
7.6.6 Dynavax Technologies Competitive Strengths & Weaknesses
7.7 Kastle therapeutics
7.7.1 Kastle therapeutics Details
7.7.2 Kastle therapeutics Major Business
7.7.3 Kastle therapeutics Oligonucleotide Therapeutics Drug Product and Services
7.7.4 Kastle therapeutics Oligonucleotide Therapeutics Drug Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Kastle therapeutics Recent Developments/Updates
7.7.6 Kastle therapeutics Competitive Strengths & Weaknesses
7.8 Akcea Therapeutics
7.8.1 Akcea Therapeutics Details
7.8.2 Akcea Therapeutics Major Business
7.8.3 Akcea Therapeutics Oligonucleotide Therapeutics Drug Product and Services
7.8.4 Akcea Therapeutics Oligonucleotide Therapeutics Drug Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Akcea Therapeutics Recent Developments/Updates
7.8.6 Akcea Therapeutics Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Oligonucleotide Therapeutics Drug Industry Chain
8.2 Oligonucleotide Therapeutics Drug Upstream Analysis
8.3 Oligonucleotide Therapeutics Drug Midstream Analysis
8.4 Oligonucleotide Therapeutics Drug Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Oligonucleotide Therapeutics Drug Introduction
1.2 World Oligonucleotide Therapeutics Drug Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Oligonucleotide Therapeutics Drug Total Market by Region (by Headquarter Location)
1.3.1 World Oligonucleotide Therapeutics Drug Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Oligonucleotide Therapeutics Drug Market Size (2018-2029)
1.3.3 China Oligonucleotide Therapeutics Drug Market Size (2018-2029)
1.3.4 Europe Oligonucleotide Therapeutics Drug Market Size (2018-2029)
1.3.5 Japan Oligonucleotide Therapeutics Drug Market Size (2018-2029)
1.3.6 South Korea Oligonucleotide Therapeutics Drug Market Size (2018-2029)
1.3.7 ASEAN Oligonucleotide Therapeutics Drug Market Size (2018-2029)
1.3.8 India Oligonucleotide Therapeutics Drug Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Oligonucleotide Therapeutics Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Oligonucleotide Therapeutics Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Oligonucleotide Therapeutics Drug Consumption Value (2018-2029)
2.2 World Oligonucleotide Therapeutics Drug Consumption Value by Region
2.2.1 World Oligonucleotide Therapeutics Drug Consumption Value by Region (2018-2023)
2.2.2 World Oligonucleotide Therapeutics Drug Consumption Value Forecast by Region (2024-2029)
2.3 United States Oligonucleotide Therapeutics Drug Consumption Value (2018-2029)
2.4 China Oligonucleotide Therapeutics Drug Consumption Value (2018-2029)
2.5 Europe Oligonucleotide Therapeutics Drug Consumption Value (2018-2029)
2.6 Japan Oligonucleotide Therapeutics Drug Consumption Value (2018-2029)
2.7 South Korea Oligonucleotide Therapeutics Drug Consumption Value (2018-2029)
2.8 ASEAN Oligonucleotide Therapeutics Drug Consumption Value (2018-2029)
2.9 India Oligonucleotide Therapeutics Drug Consumption Value (2018-2029)
3 WORLD OLIGONUCLEOTIDE THERAPEUTICS DRUG COMPANIES COMPETITIVE ANALYSIS
3.1 World Oligonucleotide Therapeutics Drug Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Oligonucleotide Therapeutics Drug Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Oligonucleotide Therapeutics Drug in 2022
3.2.3 Global Concentration Ratios (CR8) for Oligonucleotide Therapeutics Drug in 2022
3.3 Oligonucleotide Therapeutics Drug Company Evaluation Quadrant
3.4 Oligonucleotide Therapeutics Drug Market: Overall Company Footprint Analysis
3.4.1 Oligonucleotide Therapeutics Drug Market: Region Footprint
3.4.2 Oligonucleotide Therapeutics Drug Market: Company Product Type Footprint
3.4.3 Oligonucleotide Therapeutics Drug Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Oligonucleotide Therapeutics Drug Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Oligonucleotide Therapeutics Drug Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Oligonucleotide Therapeutics Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Oligonucleotide Therapeutics Drug Consumption Value Comparison
4.2.1 United States VS China: Oligonucleotide Therapeutics Drug Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Oligonucleotide Therapeutics Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Oligonucleotide Therapeutics Drug Companies and Market Share, 2018-2023
4.3.1 United States Based Oligonucleotide Therapeutics Drug Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Oligonucleotide Therapeutics Drug Revenue, (2018-2023)
4.4 China Based Companies Oligonucleotide Therapeutics Drug Revenue and Market Share, 2018-2023
4.4.1 China Based Oligonucleotide Therapeutics Drug Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Oligonucleotide Therapeutics Drug Revenue, (2018-2023)
4.5 Rest of World Based Oligonucleotide Therapeutics Drug Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Oligonucleotide Therapeutics Drug Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Oligonucleotide Therapeutics Drug Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Oligonucleotide Therapeutics Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Antisense Oligonucleotide
5.2.2 Aptamer
5.2.3 Other
5.3 Market Segment by Type
5.3.1 World Oligonucleotide Therapeutics Drug Market Size by Type (2018-2023)
5.3.2 World Oligonucleotide Therapeutics Drug Market Size by Type (2024-2029)
5.3.3 World Oligonucleotide Therapeutics Drug Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Oligonucleotide Therapeutics Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Neuromuscular Diseases
6.2.2 ATTR
6.2.3 Hepatic VOD
6.2.4 Other
6.2.5 Other
6.3 Market Segment by Application
6.3.1 World Oligonucleotide Therapeutics Drug Market Size by Application (2018-2023)
6.3.2 World Oligonucleotide Therapeutics Drug Market Size by Application (2024-2029)
6.3.3 World Oligonucleotide Therapeutics Drug Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Biogen
7.1.1 Biogen Details
7.1.2 Biogen Major Business
7.1.3 Biogen Oligonucleotide Therapeutics Drug Product and Services
7.1.4 Biogen Oligonucleotide Therapeutics Drug Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Biogen Recent Developments/Updates
7.1.6 Biogen Competitive Strengths & Weaknesses
7.2 Sarepta Therapeutics
7.2.1 Sarepta Therapeutics Details
7.2.2 Sarepta Therapeutics Major Business
7.2.3 Sarepta Therapeutics Oligonucleotide Therapeutics Drug Product and Services
7.2.4 Sarepta Therapeutics Oligonucleotide Therapeutics Drug Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Sarepta Therapeutics Recent Developments/Updates
7.2.6 Sarepta Therapeutics Competitive Strengths & Weaknesses
7.3 Jazz Pharmaceuticals
7.3.1 Jazz Pharmaceuticals Details
7.3.2 Jazz Pharmaceuticals Major Business
7.3.3 Jazz Pharmaceuticals Oligonucleotide Therapeutics Drug Product and Services
7.3.4 Jazz Pharmaceuticals Oligonucleotide Therapeutics Drug Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Jazz Pharmaceuticals Recent Developments/Updates
7.3.6 Jazz Pharmaceuticals Competitive Strengths & Weaknesses
7.4 Bausch & Lomb
7.4.1 Bausch & Lomb Details
7.4.2 Bausch & Lomb Major Business
7.4.3 Bausch & Lomb Oligonucleotide Therapeutics Drug Product and Services
7.4.4 Bausch & Lomb Oligonucleotide Therapeutics Drug Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Bausch & Lomb Recent Developments/Updates
7.4.6 Bausch & Lomb Competitive Strengths & Weaknesses
7.5 Alnylam Pharmaceuticals
7.5.1 Alnylam Pharmaceuticals Details
7.5.2 Alnylam Pharmaceuticals Major Business
7.5.3 Alnylam Pharmaceuticals Oligonucleotide Therapeutics Drug Product and Services
7.5.4 Alnylam Pharmaceuticals Oligonucleotide Therapeutics Drug Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Alnylam Pharmaceuticals Recent Developments/Updates
7.5.6 Alnylam Pharmaceuticals Competitive Strengths & Weaknesses
7.6 Dynavax Technologies
7.6.1 Dynavax Technologies Details
7.6.2 Dynavax Technologies Major Business
7.6.3 Dynavax Technologies Oligonucleotide Therapeutics Drug Product and Services
7.6.4 Dynavax Technologies Oligonucleotide Therapeutics Drug Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Dynavax Technologies Recent Developments/Updates
7.6.6 Dynavax Technologies Competitive Strengths & Weaknesses
7.7 Kastle therapeutics
7.7.1 Kastle therapeutics Details
7.7.2 Kastle therapeutics Major Business
7.7.3 Kastle therapeutics Oligonucleotide Therapeutics Drug Product and Services
7.7.4 Kastle therapeutics Oligonucleotide Therapeutics Drug Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Kastle therapeutics Recent Developments/Updates
7.7.6 Kastle therapeutics Competitive Strengths & Weaknesses
7.8 Akcea Therapeutics
7.8.1 Akcea Therapeutics Details
7.8.2 Akcea Therapeutics Major Business
7.8.3 Akcea Therapeutics Oligonucleotide Therapeutics Drug Product and Services
7.8.4 Akcea Therapeutics Oligonucleotide Therapeutics Drug Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Akcea Therapeutics Recent Developments/Updates
7.8.6 Akcea Therapeutics Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Oligonucleotide Therapeutics Drug Industry Chain
8.2 Oligonucleotide Therapeutics Drug Upstream Analysis
8.3 Oligonucleotide Therapeutics Drug Midstream Analysis
8.4 Oligonucleotide Therapeutics Drug Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Oligonucleotide Therapeutics Drug Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Oligonucleotide Therapeutics Drug Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Oligonucleotide Therapeutics Drug Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Oligonucleotide Therapeutics Drug Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Oligonucleotide Therapeutics Drug Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Oligonucleotide Therapeutics Drug Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Oligonucleotide Therapeutics Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Oligonucleotide Therapeutics Drug Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Oligonucleotide Therapeutics Drug Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Oligonucleotide Therapeutics Drug Players in 2022
Table 12. World Oligonucleotide Therapeutics Drug Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Oligonucleotide Therapeutics Drug Company Evaluation Quadrant
Table 14. Head Office of Key Oligonucleotide Therapeutics Drug Player
Table 15. Oligonucleotide Therapeutics Drug Market: Company Product Type Footprint
Table 16. Oligonucleotide Therapeutics Drug Market: Company Product Application Footprint
Table 17. Oligonucleotide Therapeutics Drug Mergers & Acquisitions Activity
Table 18. United States VS China Oligonucleotide Therapeutics Drug Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Oligonucleotide Therapeutics Drug Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Oligonucleotide Therapeutics Drug Companies, Headquarters (States, Country)
Table 21. United States Based Companies Oligonucleotide Therapeutics Drug Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Oligonucleotide Therapeutics Drug Revenue Market Share (2018-2023)
Table 23. China Based Oligonucleotide Therapeutics Drug Companies, Headquarters (Province, Country)
Table 24. China Based Companies Oligonucleotide Therapeutics Drug Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Oligonucleotide Therapeutics Drug Revenue Market Share (2018-2023)
Table 26. Rest of World Based Oligonucleotide Therapeutics Drug Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Oligonucleotide Therapeutics Drug Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Oligonucleotide Therapeutics Drug Revenue Market Share (2018-2023)
Table 29. World Oligonucleotide Therapeutics Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Oligonucleotide Therapeutics Drug Market Size by Type (2018-2023) & (USD Million)
Table 31. World Oligonucleotide Therapeutics Drug Market Size by Type (2024-2029) & (USD Million)
Table 32. World Oligonucleotide Therapeutics Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Oligonucleotide Therapeutics Drug Market Size by Application (2018-2023) & (USD Million)
Table 34. World Oligonucleotide Therapeutics Drug Market Size by Application (2024-2029) & (USD Million)
Table 35. Biogen Basic Information, Area Served and Competitors
Table 36. Biogen Major Business
Table 37. Biogen Oligonucleotide Therapeutics Drug Product and Services
Table 38. Biogen Oligonucleotide Therapeutics Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Biogen Recent Developments/Updates
Table 40. Biogen Competitive Strengths & Weaknesses
Table 41. Sarepta Therapeutics Basic Information, Area Served and Competitors
Table 42. Sarepta Therapeutics Major Business
Table 43. Sarepta Therapeutics Oligonucleotide Therapeutics Drug Product and Services
Table 44. Sarepta Therapeutics Oligonucleotide Therapeutics Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Sarepta Therapeutics Recent Developments/Updates
Table 46. Sarepta Therapeutics Competitive Strengths & Weaknesses
Table 47. Jazz Pharmaceuticals Basic Information, Area Served and Competitors
Table 48. Jazz Pharmaceuticals Major Business
Table 49. Jazz Pharmaceuticals Oligonucleotide Therapeutics Drug Product and Services
Table 50. Jazz Pharmaceuticals Oligonucleotide Therapeutics Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Jazz Pharmaceuticals Recent Developments/Updates
Table 52. Jazz Pharmaceuticals Competitive Strengths & Weaknesses
Table 53. Bausch & Lomb Basic Information, Area Served and Competitors
Table 54. Bausch & Lomb Major Business
Table 55. Bausch & Lomb Oligonucleotide Therapeutics Drug Product and Services
Table 56. Bausch & Lomb Oligonucleotide Therapeutics Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Bausch & Lomb Recent Developments/Updates
Table 58. Bausch & Lomb Competitive Strengths & Weaknesses
Table 59. Alnylam Pharmaceuticals Basic Information, Area Served and Competitors
Table 60. Alnylam Pharmaceuticals Major Business
Table 61. Alnylam Pharmaceuticals Oligonucleotide Therapeutics Drug Product and Services
Table 62. Alnylam Pharmaceuticals Oligonucleotide Therapeutics Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Alnylam Pharmaceuticals Recent Developments/Updates
Table 64. Alnylam Pharmaceuticals Competitive Strengths & Weaknesses
Table 65. Dynavax Technologies Basic Information, Area Served and Competitors
Table 66. Dynavax Technologies Major Business
Table 67. Dynavax Technologies Oligonucleotide Therapeutics Drug Product and Services
Table 68. Dynavax Technologies Oligonucleotide Therapeutics Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Dynavax Technologies Recent Developments/Updates
Table 70. Dynavax Technologies Competitive Strengths & Weaknesses
Table 71. Kastle therapeutics Basic Information, Area Served and Competitors
Table 72. Kastle therapeutics Major Business
Table 73. Kastle therapeutics Oligonucleotide Therapeutics Drug Product and Services
Table 74. Kastle therapeutics Oligonucleotide Therapeutics Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Kastle therapeutics Recent Developments/Updates
Table 76. Akcea Therapeutics Basic Information, Area Served and Competitors
Table 77. Akcea Therapeutics Major Business
Table 78. Akcea Therapeutics Oligonucleotide Therapeutics Drug Product and Services
Table 79. Akcea Therapeutics Oligonucleotide Therapeutics Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 80. Global Key Players of Oligonucleotide Therapeutics Drug Upstream (Raw Materials)
Table 81. Oligonucleotide Therapeutics Drug Typical Customers
Table 1. World Oligonucleotide Therapeutics Drug Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Oligonucleotide Therapeutics Drug Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Oligonucleotide Therapeutics Drug Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Oligonucleotide Therapeutics Drug Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Oligonucleotide Therapeutics Drug Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Oligonucleotide Therapeutics Drug Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Oligonucleotide Therapeutics Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Oligonucleotide Therapeutics Drug Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Oligonucleotide Therapeutics Drug Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Oligonucleotide Therapeutics Drug Players in 2022
Table 12. World Oligonucleotide Therapeutics Drug Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Oligonucleotide Therapeutics Drug Company Evaluation Quadrant
Table 14. Head Office of Key Oligonucleotide Therapeutics Drug Player
Table 15. Oligonucleotide Therapeutics Drug Market: Company Product Type Footprint
Table 16. Oligonucleotide Therapeutics Drug Market: Company Product Application Footprint
Table 17. Oligonucleotide Therapeutics Drug Mergers & Acquisitions Activity
Table 18. United States VS China Oligonucleotide Therapeutics Drug Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Oligonucleotide Therapeutics Drug Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Oligonucleotide Therapeutics Drug Companies, Headquarters (States, Country)
Table 21. United States Based Companies Oligonucleotide Therapeutics Drug Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Oligonucleotide Therapeutics Drug Revenue Market Share (2018-2023)
Table 23. China Based Oligonucleotide Therapeutics Drug Companies, Headquarters (Province, Country)
Table 24. China Based Companies Oligonucleotide Therapeutics Drug Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Oligonucleotide Therapeutics Drug Revenue Market Share (2018-2023)
Table 26. Rest of World Based Oligonucleotide Therapeutics Drug Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Oligonucleotide Therapeutics Drug Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Oligonucleotide Therapeutics Drug Revenue Market Share (2018-2023)
Table 29. World Oligonucleotide Therapeutics Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Oligonucleotide Therapeutics Drug Market Size by Type (2018-2023) & (USD Million)
Table 31. World Oligonucleotide Therapeutics Drug Market Size by Type (2024-2029) & (USD Million)
Table 32. World Oligonucleotide Therapeutics Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Oligonucleotide Therapeutics Drug Market Size by Application (2018-2023) & (USD Million)
Table 34. World Oligonucleotide Therapeutics Drug Market Size by Application (2024-2029) & (USD Million)
Table 35. Biogen Basic Information, Area Served and Competitors
Table 36. Biogen Major Business
Table 37. Biogen Oligonucleotide Therapeutics Drug Product and Services
Table 38. Biogen Oligonucleotide Therapeutics Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Biogen Recent Developments/Updates
Table 40. Biogen Competitive Strengths & Weaknesses
Table 41. Sarepta Therapeutics Basic Information, Area Served and Competitors
Table 42. Sarepta Therapeutics Major Business
Table 43. Sarepta Therapeutics Oligonucleotide Therapeutics Drug Product and Services
Table 44. Sarepta Therapeutics Oligonucleotide Therapeutics Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Sarepta Therapeutics Recent Developments/Updates
Table 46. Sarepta Therapeutics Competitive Strengths & Weaknesses
Table 47. Jazz Pharmaceuticals Basic Information, Area Served and Competitors
Table 48. Jazz Pharmaceuticals Major Business
Table 49. Jazz Pharmaceuticals Oligonucleotide Therapeutics Drug Product and Services
Table 50. Jazz Pharmaceuticals Oligonucleotide Therapeutics Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Jazz Pharmaceuticals Recent Developments/Updates
Table 52. Jazz Pharmaceuticals Competitive Strengths & Weaknesses
Table 53. Bausch & Lomb Basic Information, Area Served and Competitors
Table 54. Bausch & Lomb Major Business
Table 55. Bausch & Lomb Oligonucleotide Therapeutics Drug Product and Services
Table 56. Bausch & Lomb Oligonucleotide Therapeutics Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Bausch & Lomb Recent Developments/Updates
Table 58. Bausch & Lomb Competitive Strengths & Weaknesses
Table 59. Alnylam Pharmaceuticals Basic Information, Area Served and Competitors
Table 60. Alnylam Pharmaceuticals Major Business
Table 61. Alnylam Pharmaceuticals Oligonucleotide Therapeutics Drug Product and Services
Table 62. Alnylam Pharmaceuticals Oligonucleotide Therapeutics Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Alnylam Pharmaceuticals Recent Developments/Updates
Table 64. Alnylam Pharmaceuticals Competitive Strengths & Weaknesses
Table 65. Dynavax Technologies Basic Information, Area Served and Competitors
Table 66. Dynavax Technologies Major Business
Table 67. Dynavax Technologies Oligonucleotide Therapeutics Drug Product and Services
Table 68. Dynavax Technologies Oligonucleotide Therapeutics Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Dynavax Technologies Recent Developments/Updates
Table 70. Dynavax Technologies Competitive Strengths & Weaknesses
Table 71. Kastle therapeutics Basic Information, Area Served and Competitors
Table 72. Kastle therapeutics Major Business
Table 73. Kastle therapeutics Oligonucleotide Therapeutics Drug Product and Services
Table 74. Kastle therapeutics Oligonucleotide Therapeutics Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Kastle therapeutics Recent Developments/Updates
Table 76. Akcea Therapeutics Basic Information, Area Served and Competitors
Table 77. Akcea Therapeutics Major Business
Table 78. Akcea Therapeutics Oligonucleotide Therapeutics Drug Product and Services
Table 79. Akcea Therapeutics Oligonucleotide Therapeutics Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 80. Global Key Players of Oligonucleotide Therapeutics Drug Upstream (Raw Materials)
Table 81. Oligonucleotide Therapeutics Drug Typical Customers
LIST OF FIGURES
Figure 1. Oligonucleotide Therapeutics Drug Picture
Figure 2. World Oligonucleotide Therapeutics Drug Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Oligonucleotide Therapeutics Drug Total Market Size (2018-2029) & (USD Million)
Figure 4. World Oligonucleotide Therapeutics Drug Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Oligonucleotide Therapeutics Drug Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Oligonucleotide Therapeutics Drug Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Oligonucleotide Therapeutics Drug Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Oligonucleotide Therapeutics Drug Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Oligonucleotide Therapeutics Drug Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Oligonucleotide Therapeutics Drug Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Oligonucleotide Therapeutics Drug Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Oligonucleotide Therapeutics Drug Revenue (2018-2029) & (USD Million)
Figure 13. Oligonucleotide Therapeutics Drug Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Oligonucleotide Therapeutics Drug Consumption Value (2018-2029) & (USD Million)
Figure 16. World Oligonucleotide Therapeutics Drug Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Oligonucleotide Therapeutics Drug Consumption Value (2018-2029) & (USD Million)
Figure 18. China Oligonucleotide Therapeutics Drug Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Oligonucleotide Therapeutics Drug Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Oligonucleotide Therapeutics Drug Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Oligonucleotide Therapeutics Drug Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Oligonucleotide Therapeutics Drug Consumption Value (2018-2029) & (USD Million)
Figure 23. India Oligonucleotide Therapeutics Drug Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Oligonucleotide Therapeutics Drug by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Oligonucleotide Therapeutics Drug Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Oligonucleotide Therapeutics Drug Markets in 2022
Figure 27. United States VS China: Oligonucleotide Therapeutics Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Oligonucleotide Therapeutics Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Oligonucleotide Therapeutics Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Oligonucleotide Therapeutics Drug Market Size Market Share by Type in 2022
Figure 31. Antisense Oligonucleotide
Figure 32. Aptamer
Figure 33. Other
Figure 34. World Oligonucleotide Therapeutics Drug Market Size Market Share by Type (2018-2029)
Figure 35. World Oligonucleotide Therapeutics Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Oligonucleotide Therapeutics Drug Market Size Market Share by Application in 2022
Figure 37. Neuromuscular Diseases
Figure 38. ATTR
Figure 39. Hepatic VOD
Figure 40. Other
Figure 41. Oligonucleotide Therapeutics Drug Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
Figure 1. Oligonucleotide Therapeutics Drug Picture
Figure 2. World Oligonucleotide Therapeutics Drug Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Oligonucleotide Therapeutics Drug Total Market Size (2018-2029) & (USD Million)
Figure 4. World Oligonucleotide Therapeutics Drug Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Oligonucleotide Therapeutics Drug Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Oligonucleotide Therapeutics Drug Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Oligonucleotide Therapeutics Drug Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Oligonucleotide Therapeutics Drug Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Oligonucleotide Therapeutics Drug Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Oligonucleotide Therapeutics Drug Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Oligonucleotide Therapeutics Drug Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Oligonucleotide Therapeutics Drug Revenue (2018-2029) & (USD Million)
Figure 13. Oligonucleotide Therapeutics Drug Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Oligonucleotide Therapeutics Drug Consumption Value (2018-2029) & (USD Million)
Figure 16. World Oligonucleotide Therapeutics Drug Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Oligonucleotide Therapeutics Drug Consumption Value (2018-2029) & (USD Million)
Figure 18. China Oligonucleotide Therapeutics Drug Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Oligonucleotide Therapeutics Drug Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Oligonucleotide Therapeutics Drug Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Oligonucleotide Therapeutics Drug Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Oligonucleotide Therapeutics Drug Consumption Value (2018-2029) & (USD Million)
Figure 23. India Oligonucleotide Therapeutics Drug Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Oligonucleotide Therapeutics Drug by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Oligonucleotide Therapeutics Drug Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Oligonucleotide Therapeutics Drug Markets in 2022
Figure 27. United States VS China: Oligonucleotide Therapeutics Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Oligonucleotide Therapeutics Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Oligonucleotide Therapeutics Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Oligonucleotide Therapeutics Drug Market Size Market Share by Type in 2022
Figure 31. Antisense Oligonucleotide
Figure 32. Aptamer
Figure 33. Other
Figure 34. World Oligonucleotide Therapeutics Drug Market Size Market Share by Type (2018-2029)
Figure 35. World Oligonucleotide Therapeutics Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Oligonucleotide Therapeutics Drug Market Size Market Share by Application in 2022
Figure 37. Neuromuscular Diseases
Figure 38. ATTR
Figure 39. Hepatic VOD
Figure 40. Other
Figure 41. Oligonucleotide Therapeutics Drug Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
